Chronic kidney disease and anemia: application of ferrous bisglycinate chelate for correction of iron deficiency in patients with chronic kidney disease

Main Article Content

D.D. Ivanov


Anemia is a component of chronic kidney disease, having erythropoietin- and iron deficiency nature. 2012 KDIGO guidelines determine anemia as a hemoglobin concentration < 120 g/l in women and < 130 g/l in men. An iron deficiency occurs in more than 50 % of patients with non-dialysis-dependent chronic kidney disease and in the majority of patients receiving dialysis. For the diagnosis of iron deficiency, the value of serum ferritin level and transferrin saturation are used. Reduction of any of these indicators is the basis for hemoglobin correction by iron compounds. Iron deficiency increases with existing inflammation, its need increases with erythropoietin treatment. Among oral molecules, bivalent iron salts or those that are not hydrolyzed have the best absorption profile, high bioavailability and well regulate iron deficiency. The article considers Tecnofer as an example of compounds with certain advantages for the iron deficiency correction in anemia in patients with chronic kidney disease.

Article Details

How to Cite
Ivanov, D. “Chronic Kidney Disease and Anemia: Application of Ferrous Bisglycinate Chelate for Correction of Iron Deficiency in Patients With Chronic Kidney Disease”. KIDNEYS, vol. 8, no. 3, Aug. 2019, pp. 157-60, doi:10.22141/2307-1257.8.3.2019.176454.
To Help the Practitioner


Kidney Disease: Improving Global Outcomes (KDIGO); Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl. 2012Aug;2(4):279-335.

Fishbane S, Spinowitz B. Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. Am J Kidney Dis. 2018 Mar;71(3):423-435. doi: 10.1053/j.ajkd.2017.09.026.

European Food Safety Authority (EFSA). Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to Ferrous bisglycinate as a source of iron for use in the manufacturing of foods ad in food supplements. EFSA Journal. 2006;(299):1-17. doi: 10.2903/j.efsa.2006.299.

Ashmead HD. The absorption and metabolism of iron amino acid chelate. Arch Latinoam Nutr. 2001 Mar;51(1 Suppl 1):13-21.

Bertini M, Kiril'chuk ME, Medved' VI. Ferrous iron of new generation for the prevention of anemia in pregnant women. Zdorov’ja Ukrai'ny. Akusherstvo, Reproduktologija. 2018;(32):9. (in Russian).

Pineda O, Ashmead HD. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition. 2001 May;17(5):381-4.

Szarfarc SC, de Cassana LM, Fujimori E, Guerra-Shinohara EM, de Oliveira IM. Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latinoam Nutr. 2001 Mar;51(1 Suppl 1):42-7.